Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells

被引：3

作者：

Zhou, Guangyu ^{[1
,2
]}

Fu, Shengyu ^{[1
]}

Zhang, Yunsen ^{[3
]}

Li, Shuang ^{[4
]}

Guo, Ziang ^{[1
]}

Ouyang, Defang ^{[3
]}

Ying, Tianlei ^{[5
]}

Lu, Yinying ^{[4
]}

Zhao, Qi ^{[1
,2
]}

机构：

[1] Univ Macau, Inst Translat Med, Fac Hlth Sci, Canc Ctr, Taipa 999078, Macau, Peoples R China

[2] Univ Macau, MoE Frontiers Sci Ctr Precis Oncol, Taipa 999078, Macau, Peoples R China

[3] Univ Macau, Inst Chinese Med Sci, Taipa 999078, Macau, Peoples R China

[4] Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing 100036, Peoples R China

[5] Fudan Univ, Shanghai Inst Infect Dis & Biosecur, Shanghai Engn Res Ctr Synthet Immunol, MOE NHC CAMS Key Lab Med Mol Virol,Sch Basic Med S, Shanghai 200032, Peoples R China

来源：

ANTIBODIES | 2024年 / 13卷 / 02期

基金：

国家重点研发计划;

关键词：

HER2; monoclonal antibody; CAR-T cell; trastuzumab; BREAST-CANCER; T-CELLS; HERCEPTIN;

D O I：

10.3390/antib13020045

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Chimeric antigen receptor (CAR) T cell therapy shows promise in treating malignant tumors. However, the use of human epidermal growth factor receptor-2 (HER2) CAR-T cells carries the risk of severe toxicity, including cytokine release syndrome, due to their "on-target off-tumor" recognition of HER2. Enhancing the quality and functionality of HER2 CARs could greatly improve the therapeutic potential of CAR-T cells. In this study, we developed a novel anti-HER2 monoclonal antibody, Ab8, which targets domain III of HER2, distinct from the domain IV recognition of trastuzumab. Although two anti-HER2 mAbs induced similar levels of antibody-dependent cellular cytotoxicity, trastuzumab-based CAR-T cells exhibited potent antitumor activity against HER2-positive cancer cells. In conclusion, our findings provide scientific evidence that antibody recognition of the membrane-proximal domain promotes the anti-tumor response of HER2-specific CAR-T cells.

引用

页数：12

共 30 条

[1] IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype [J].

Alizadeh, Darya ;

Wong, Robyn A. ;

Yang, Xin ;

Wang, Dongrui ;

Pecoraro, Joseph R. ;

Kuo, Cheng-Fu ;

Aguilar, Brenda ;

Qi, Yue ;

Ann, David K. ;

Starr, Renate ;

Urak, Ryan ;

Wang, Xiuli ;

Forman, Stephen J. ;

Brown, Christine E. .

CANCER IMMUNOLOGY RESEARCH, 2019, 7 (05) :759-772

[2] Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress [J].

Budi, Hendrik Setia ;

Ahmad, Firdaus Nuri ;

Achmad, Harun ;

Ansari, Mohammad Javed ;

Mikhailova, Maria Vladimirovna ;

Suksatan, Wanich ;

Chupradit, Supat ;

Shomali, Navid ;

Marofi, Faroogh .

STEM CELL RESEARCH & THERAPY, 2022, 13 (01)

[3] Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design [J].

Cannon, Daniel A. ;

Shan, Lu ;

Du, Qun ;

Shirinian, Lena ;

Rickert, Keith W. ;

Rosenthal, Kim L. ;

Korade, Martin, III ;

van Vlerken-Ysla, Lilian E. ;

Buchanan, Andrew ;

Vaughan, Tristan J. ;

Damschroder, Melissa M. ;

Popovic, Bojana .

PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (05)

[4] Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer [J].

Cao, Yu ;

Rodgers, David T. ;

Du, Juanjuan ;

Ahmad, Insha ;

Hampton, Eric N. ;

Ma, Jennifer S. Y. ;

Mazagova, Magdalena ;

Choi, Sei-hyun ;

Yun, Hwa Young ;

Xiao, Han ;

Yang, Pengyu ;

Luo, Xiaozhou ;

Lim, Reyna K. V. ;

Pugh, Holly M. ;

Wang, Feng ;

Kazane, Stephanie A. ;

Wright, Timothy M. ;

Kim, Chan Hyuk ;

Schultz, Peter G. ;

Young, Travis S. .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (26) :7520-7524

[5] A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells [J].

Chen, Zhizhen ;

Liu, Jie ;

Chu, Dafeng ;

Shan, Yaming ;

Ma, Guixing ;

Zhang, Hongmin ;

Zhang, Xiaohua Douglas ;

Wang, Pu ;

Chen, Qiang ;

Deng, Chuxia ;

Chen, Weizao ;

Dimitrov, Dimiter S. ;

Zhao, Qi .

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018, 14 (07) :799-806

[6] Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab [J].

Cho, HS ;

Mason, K ;

Ramyar, KX ;

Stanley, AM ;

Gabelli, SB ;

Denney, DW ;

Leahy, DJ .

NATURE, 2003, 421 (6924) :756-760

[7] Immunotherapies against HER2-Positive Breast Cancer [J].

Duro-Sanchez, Santiago ;

Alonso, Macarena Roman ;

Arribas, Joaquin .

CANCERS, 2023, 15 (04)

[8] HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments [J].

Essadi, Ismail ;

Benbrahim, Zineb ;

Kaakoua, Mohamed ;

Reverdy, Thibaut ;

Corbaux, Pauline ;

Freyer, Gilles .

CANCERS, 2023, 15 (06)

[9] IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models [J].

Guo, Siqi ;

Smeltz, Ronald B. ;

Nanajian, Anthony ;

Heller, Richard .

FRONTIERS IN IMMUNOLOGY, 2021, 11

[10] DrugBank 6.0: the DrugBank Knowledgebase for 2024 [J].

Knox, Craig ;

Wilson, Mike ;

Klinger, Christen M. ;

Franklin, Mark ;

Oler, Eponine ;

Wilson, Alex ;

Pon, Allison ;

Cox, Jordan ;

Chin, Na Eun ;

Strawbridge, Seth A. ;

Garcia-Patino, Marysol ;

Kruger, Ray ;

Sivakumaran, Aadhavya ;

Sanford, Selena ;

Doshi, Rahil ;

Khetarpal, Nitya ;

Fatokun, Omolola ;

Doucet, Daphnee ;

Zubkowski, Ashley ;

Rayat, DorsaYahya ;

Jackson, Hayley ;

Harford, Karxena ;

Anjum, Afia ;

Zakir, Mahi ;

Wang, Fei ;

Tian, Siyang ;

Lee, Brian ;

Liigand, Jaanus ;

Peters, Harrison ;

Wang, Ruo Qi ;

Nguyen, Tue ;

So, Denise ;

Sharp, Matthew ;

da Silva, Rodolfo ;

Gabriel, Cyrella ;

Scantlebury, Joshua ;

Jasinski, Marissa ;

Ackerman, David ;

Jewison, Timothy ;

Sajed, Tanvir ;

Gautam, Vasuk ;

Wishart, David S. .

NUCLEIC ACIDS RESEARCH, 2023, 52 (D1) :D1265-D1275

← 1 2 3 →